STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage (STO:BIOTA) is expanding its direct sales coverage and will begin selling SPE products directly into non-pharma application areas within the UK starting January 18, 2010. Sales to non-pharmaceutical based markets and customers have previously been managed by a distributor.
